- Home
- TRSG vs INKT Comparison
TRSG vs INKT Comparison
Compare TRSG & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- INKT
- Stock Information
- Founded
- TRSG 1996
- INKT 2017
- Country
- TRSG Singapore
- INKT United States
- Employees
- TRSG N/A
- INKT N/A
- Industry
- TRSG
- INKT Medicinal Chemicals and Botanical Products
- Sector
- TRSG
- INKT Health Care
- Exchange
- TRSG NYSE
- INKT Nasdaq
- Market Cap
- TRSG 27.0M
- INKT 28.9M
- IPO Year
- TRSG 2024
- INKT 2021
- Fundamental
- Price
- TRSG $1.64
- INKT $7.28
- Analyst Decision
- TRSG
- INKT Strong Buy
- Analyst Count
- TRSG 0
- INKT 2
- Target Price
- TRSG N/A
- INKT $37.50
- AVG Volume (30 Days)
- TRSG 6.2K
- INKT 14.7K
- Earning Date
- TRSG 05-14-2025
- INKT 08-12-2025
- Dividend Yield
- TRSG N/A
- INKT N/A
- EPS Growth
- TRSG N/A
- INKT N/A
- EPS
- TRSG N/A
- INKT N/A
- Revenue
- TRSG $12,810,249.00
- INKT N/A
- Revenue This Year
- TRSG N/A
- INKT N/A
- Revenue Next Year
- TRSG N/A
- INKT N/A
- P/E Ratio
- TRSG N/A
- INKT N/A
- Revenue Growth
- TRSG N/A
- INKT N/A
- 52 Week Low
- TRSG $1.00
- INKT $4.56
- 52 Week High
- TRSG $4.57
- INKT $13.79
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- INKT 51.20
- Support Level
- TRSG N/A
- INKT $6.80
- Resistance Level
- TRSG N/A
- INKT $7.55
- Average True Range (ATR)
- TRSG 0.00
- INKT 0.34
- MACD
- TRSG 0.00
- INKT -0.01
- Stochastic Oscillator
- TRSG 0.00
- INKT 36.71
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.